Revealed: US Cystic Fibrosis Market Share Expected to Expand Rapidly Through 2035
The US cystic fibrosis market is on track for substantial expansion, with expectations of significant shifts in market share among leading pharmaceutical companies. The market is projected to grow from a valuation of $1.44 billion in 2024 to an impressive $5.48 billion by 2035. This growth trajectory, at a CAGR of 12.95%, suggests a dynamic competitive landscape where companies are increasingly...
0 Comments 0 Shares 7 Views 0 Reviews